Tamsulosin and Facial paralysis - a phase IV clinical study of FDA data

Summary:

Facial paralysis is found among people who take Tamsulosin, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Tamsulosin and have Facial paralysis. It is created by eHealthMe based on reports of 51,516 people who have side effects when taking Tamsulosin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 17, 2022

51,516 people reported to have side effects when taking Tamsulosin.
Among them, 23 people (0.04%) have Facial paralysis.


What is Tamsulosin?

Tamsulosin has active ingredients of tamsulosin. It is often used in prostate examination abnormal. eHealthMe is studying from 52,653 Tamsulosin users for its effectiveness, alternative drugs and more.

What is Facial paralysis?

Facial paralysis (loss of function of face muscle) is found to be associated with 1,461 drugs and 878 conditions by eHealthMe.

Number of Tamsulosin and Facial paralysis reports submitted per year:

Could Tamsulosin cause Facial paralysis?

Gender of people who have Facial paralysis when taking Tamsulosin *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Facial paralysis when taking Tamsulosin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 12.5 %
  • 60+: 87.5 %

Common drugs people take besides Tamsulosin *:

  1. Heparin: 3 people, 13.04%
  2. Eliquis: 3 people, 13.04%
  3. Acidophilus: 2 people, 8.70%
  4. Breo Ellipta: 2 people, 8.70%
  5. Metformin: 2 people, 8.70%
  6. Zantac: 2 people, 8.70%
  7. Pantoprazole: 2 people, 8.70%
  8. Proair Hfa: 2 people, 8.70%
  9. Singulair: 2 people, 8.70%
  10. Spiriva: 2 people, 8.70%

Common side effects people have besides Facial paralysis *:

  1. Pneumonia: 4 people, 17.39%
  2. Urinary Tract Infection: 4 people, 17.39%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 17.39%
  4. Prostatitis (inflammation of the prostate gland): 3 people, 13.04%
  5. Speech Impairment (Adult) (inability to speak (adult)): 3 people, 13.04%
  6. Dizziness: 3 people, 13.04%
  7. Oxygen Saturation Decreased: 3 people, 13.04%
  8. Hemiparesis (weakness on one side of the body): 2 people, 8.70%
  9. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 8.70%
  10. Kidney Stones: 2 people, 8.70%

Common conditions people have *:

  1. High Blood Pressure: 4 people, 17.39%
  2. Prostatic Disorder: 3 people, 13.04%
  3. Multiple Myeloma (cancer of the plasma cells): 3 people, 13.04%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 13.04%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.70%
  6. Parkinson's Disease: 2 people, 8.70%
  7. Diabetes: 2 people, 8.70%
  8. Movement - Unpredictable Or Jerky: 2 people, 8.70%
  9. Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 8.70%
  10. Immunodeficiency Common Variable: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tamsulosin and have Facial paralysis?

Check whether Facial paralysis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Tamsulosin:

Facial paralysis treatments and more:

COVID vaccines that are related to Facial paralysis:

How severe was Facial paralysis and when was it recovered:

Expand to all the drugs that have ingredients of tamsulosin:

Common drugs associated with Facial paralysis:

All the drugs that are associated with Facial paralysis:

Common conditions associated with Facial paralysis:

All the conditions that are associated with Facial paralysis:

How the study uses the data?

The study uses data from the FDA. It is based on tamsulosin (the active ingredients of Tamsulosin) and Tamsulosin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: